| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |